×
Back to Agenda
Session 2: Update from FDA
Session Chair(s)
Wayne Pines
President, Health Care, United States
This session will provide an update on recent guidances and enforcement actions taken by the FDA.
Learning Objective : At the conclusion of this session, participants should be able to:- Identify recent FDA enforcement actions
- Discuss trends that are taking place in enforcement
- Describe FDA enforcement priorities
- Discuss recent policy and guidance development for medical products
Speaker(s)
Elizabeth Pepinsky, JD
Health Science Policy Analyst, FDA, United States
Speaker
Thomas W. Abrams, MBA, RPH
Retired, Director, Office of Prescription Drug Promotion, OMP, CDER, Former FDA, United States
Speaker
Lisa Stockbridge, PHD
Branch Chief, Advertising and Promotional Labeling Branch, OCBQ, CBER, FDA, United States
Speaker
Deborah Wolf, JD
Regulatory Counsel, OPEQ , Regulatory Policy, CDRH, FDA, United States
Speaker
Have an account?